Skip to main content
. 2022 Jul 4;11(13):3890. doi: 10.3390/jcm11133890

Table 2.

Characteristics of the reports of patients with sleep-related eating disorder (SRED) according to drug classes.

Drug Class Age (Mean ± SD) Female (%) Serious (%)
Nonbenzodiazepines 49.7 (±16.6) 70.4 64.0
Serotonin-norepinephrine reuptake inhibitors 44.8 (±15.6) 68.3 62.3
Second-generation antipsychotics 41.1 (±14.5) 57.7 45.2
Sodium oxybate 39.7 (±17.4) 68.2 48.6
Psychostimulants 37.2 (±15.8) 65.0 54.3

SD: Standard Deviation.